Cargando…

Explorative probes and biomarkers, chronic Salmonella infections and future vaccines

Detalles Bibliográficos
Autores principales:	Michán, Carmen, Ramos, Juan‐Luis, Daniels, Craig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815267/ https://www.ncbi.nlm.nih.gov/pubmed/22103324 http://dx.doi.org/10.1111/j.1751-7915.2011.00315.x

Ejemplares similares

Cold is cool, the human microbiota and taking multiple SIPs
por: Daniels, Craig, et al.
Publicado: (2011)

New molecular techniques for pathogen analysis, in silico determination of RND efflux pump substrate specificity, shotgun proteomic monitoring of bioremediation and yeast bio‐applications
por: Michán, Carmen, et al.
Publicado: (2010)

Microbial Biotechnology: biofuels, genotoxicity reporters and robust agro‐ecosystems
por: Daniels, Craig, et al.
Publicado: (2010)

Struggling to get a universal meningococcal vaccine and novel uses for bacterial toxins in cancer treatment
por: Daniels, Craig, et al.
Publicado: (2010)

New molecular tools for enhancing methane production, explaining thermodynamically limited lifestyles and other important biotechnological issues
por: Daniels, Craig, et al.
Publicado: (2009)

Directed evolution, natural products for cancer chemotherapy, and micro‐biosensing robots
por: Daniels, Craig, et al.
Publicado: (2011)

The heat, drugs and knockout systems of Microbial Biotechnology
por: Daniels, Craig, et al.
Publicado: (2009)

Metabolic engineering, new antibiotics and biofilm viscoelasticity
por: Daniels, Craig, et al.
Publicado: (2010)

Sugar (ribose), spice (peroxidase) and all things nice (laccase hair‐dyes)
por: Michán, Carmen, et al.
Publicado: (2010)

Evolution of antibiotic resistance, catabolic pathways and niche colonization
por: Molina‐Santiago, Carlos, et al.
Publicado: (2012)

A broad range of themes in Microbial Biotechnology
por: Daniels, Craig, et al.
Publicado: (2009)

Microbial Biotechnology from medicine to bacterial population dynamics
por: Daniels, Craig, et al.
Publicado: (2009)

Gut microbiota: in sickness and in health
por: Huertas, M José, et al.
Publicado: (2014)

Paving the way for the production of secretory proteins by yeast cell factories
por: Huertas, Maria José, et al.
Publicado: (2019)

Bacteria, archae, fungi and viruses: it takes a community to eliminate waste
por: Siles, José Angel, et al.
Publicado: (2019)

Indispensable or toxic? The phosphate versus arsenate debate
por: Huertas, M José, et al.
Publicado: (2013)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Twenty one important things you should know
por: Michán, Carmen, et al.
Publicado: (2009)

Recognition of Salmonella by Dectin-1 induces presentation of peptide antigen to type B T cells
por: Jackson, Nicola, et al.
Publicado: (2014)

Highlight: Genomic Insights into the Past and Future of the Black Rhinoceros
por: McGrath, Casey
Publicado: (2023)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

Neurotrophic factor therapy for Parkinson's disease: past, present and future
por: Sullivan, Aideen M., et al.
Publicado: (2016)

Antigen targeting to dendritic cells: Still a place in future immunotherapy?
por: Stoitzner, Patrizia, et al.
Publicado: (2022)

Plasma pTau181 as a biomarker for Alzheimer's disease
por: Meng, Jie, et al.
Publicado: (2020)

Saliva biomarkers in neurological disorders: A “spitting image” of brain health?
por: Walton, Emma Louise
Publicado: (2018)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injury
por: Shin, Samuel S., et al.
Publicado: (2015)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

Going back to the future with Guthrie-powered epigenome-wide association studies
por: Cruickshank, Mark N, et al.
Publicado: (2012)

Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control
por: Yang, Jianshe
Publicado: (2021)

A next‐generation vaccine for broader and long‐lasting COVID‐19 protection
por: Xi, Jinxiang, et al.
Publicado: (2022)

Plant Pollen Grains: A Move Towards Green Drug and Vaccine Delivery Systems
por: Iravani, Siavash, et al.
Publicado: (2021)

The inflammasome: Friend or foe in Chlamydia infection?
por: Walton, Emma Louise
Publicado: (2016)

The curious case of IL‐33 in homeostasis and infection
por: Nadafi, Reza, et al.
Publicado: (2020)

Oxysterol-EBI2 signaling in immune regulation and viral infection
por: Daugvilaite, Viktorija, et al.
Publicado: (2014)

Probing the influence of mutations on FUS condensates, one molecule at a time
por: Chattopadhyay, Krishnananda
Publicado: (2021)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

Experimental and natural infections in MyD88‐ and IRAK‐4‐deficient mice and humans
por: von Bernuth, Horst, et al.
Publicado: (2012)

Epstein Barr virus infection and immune defense related to HLA‐DR15: consequences for multiple sclerosis
por: Olsson, Tomas
Publicado: (2020)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i4vd4udconfe5qug7qq8a4jigu